These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7532270)

  • 1. Characterization of the anti-HIV-1 activity of 3,4-dihydro-2-alkoxy-6-benzyl-4-oxopyrimidines (DABOs), new non-nucleoside reverse transcriptase inhibitors.
    Tramontano E; Marongiu ME; de Montis A; Loi AG; Artico M; Massa S; Mai A; la Colla P
    New Microbiol; 1994 Oct; 17(4):269-79. PubMed ID: 7532270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-aided design, synthesis, and anti-HIV-1 activity in vitro of 2-alkylamino-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as novel potent non-nucleoside reverse transcriptase inhibitors, also active against the Y181C variant.
    Ragno R; Mai A; Sbardella G; Artico M; Massa S; Musiu C; Mura M; Marturana F; Cadeddu A; La Colla P
    J Med Chem; 2004 Feb; 47(4):928-34. PubMed ID: 14761194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective and synergistic inhibition of human immunodeficiency virus type 1 reverse transcriptase by a non-nucleoside inhibitor, MKC-442.
    Yuasa S; Sadakata Y; Takashima H; Sekiya K; Inouye N; Ubasawa M; Baba M
    Mol Pharmacol; 1993 Oct; 44(4):895-900. PubMed ID: 7694070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
    Periclou AP; Nandy P; Avramis VI
    In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of N3-methyl derivative of 3'-azido-3'-deoxythymidine 5'-triphosphate on the activity of HIV-1 reverse transcriptase.
    Nakane H; Suzuki A; Nakata Y; Kitade Y; Hirota K; Maki Y; Ono K
    Nucleic Acids Symp Ser; 1991; (25):27-8. PubMed ID: 1726810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Alkyl-2-(alkylthio)-6-(2,6-dihalophenylmethyl)-3, 4-dihydropyrimidin-4(3H)-ones: novel potent and selective dihydro-alkoxy-benzyl-oxopyrimidine derivatives.
    Mai A; Artico M; Sbardella G; Massa S; Novellino E; Greco G; Loi AG; Tramontano E; Marongiu ME; La Colla P
    J Med Chem; 1999 Feb; 42(4):619-27. PubMed ID: 10052969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydro(alkylthio)(naphthylmethyl)oxopyrimidines: novel non-nucleoside reverse transcriptase inhibitors of the S-DABO series.
    Mai A; Artico M; Sbardella G; Quartarone S; Massa S; Loi AG; De Montis A; Scintu F; Putzolu M; La Colla P
    J Med Chem; 1997 May; 40(10):1447-54. PubMed ID: 9154967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3'-Azido-3',5'-dideoxythymidine-5'-methylphosphonic acid diphosphate: synthesis and HIV-1 reverse transcriptase inhibition.
    Freeman GA; Rideout JL; Miller WH; Reardon JE
    J Med Chem; 1992 Aug; 35(17):3192-6. PubMed ID: 1380561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-steady-state kinetic characterization of wild type and 3'-azido-3'-deoxythymidine (AZT) resistant human immunodeficiency virus type 1 reverse transcriptase: implication of RNA directed DNA polymerization in the mechanism of AZT resistance.
    Kerr SG; Anderson KS
    Biochemistry; 1997 Nov; 36(46):14064-70. PubMed ID: 9369478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationship studies on new DABOS: effect of substitutions at pyrimidine C-5 and C-6 positions on anti-HIV-1 activity.
    Sbardella G; Mai A; Artico M; Chimenti P; Massa S; Loddo R; Marongiu ME; La Collat P; Pani A
    Antivir Chem Chemother; 2001 Jan; 12(1):37-50. PubMed ID: 11437321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design, synthesis, and biological evaluation of conformationally restricted novel 2-alkylthio-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    Mai A; Sbardella G; Artico M; Ragno R; Massa S; Novellino E; Greco G; Lavecchia A; Musiu C; La Colla M; Murgioni C; La Colla P; Loddo R
    J Med Chem; 2001 Aug; 44(16):2544-54. PubMed ID: 11472208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Alkyl-2-alkylamino-6-(2,6-difluorophenylalkyl)-3,4-dihydropyrimidin-4(3H)-ones, a new series of potent, broad-spectrum non-nucleoside reverse transcriptase inhibitors belonging to the DABO family.
    Mai A; Artico M; Ragno R; Sbardella G; Massa S; Musiu C; Mura M; Marturana F; Cadeddu A; Maga G; La Colla P
    Bioorg Med Chem; 2005 Mar; 13(6):2065-77. PubMed ID: 15727860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus type 1 reverse transcriptase. 3'-Azidodeoxythymidine 5'-triphosphate inhibition indicates two-step binding for template-primer.
    Jaju M; Beard WA; Wilson SH
    J Biol Chem; 1995 Apr; 270(17):9740-7. PubMed ID: 7537269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of HIV-1 reverse transcriptase and its mutants to inhibition by azidothymidine triphosphate.
    Carroll SS; Geib J; Olsen DB; Stahlhut M; Shafer JA; Kuo LC
    Biochemistry; 1994 Mar; 33(8):2113-20. PubMed ID: 7509634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DABOs as candidates to prevent mucosal HIV transmission.
    Pani A; Musiu C; Loi AG; Mai A; Loddo R; La Colla P; Marongiu ME
    Antivir Chem Chemother; 2001; 12 Suppl 1():51-9. PubMed ID: 11594689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of HIV-1 reverse transcriptase and fidelity of in vitro DNA replication.
    Abbotts J; Wilson SH
    J Enzyme Inhib; 1992; 6(1):35-46. PubMed ID: 1285301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological properties of novel 2-aminopyrimidin-4(3H)-ones highly potent against HIV-1 mutant strains.
    Mai A; Artico M; Rotili D; Tarantino D; Clotet-Codina I; Armand-Ugón M; Ragno R; Simeoni S; Sbardella G; Nawrozkij MB; Samuele A; Maga G; Esté JA
    J Med Chem; 2007 Nov; 50(22):5412-24. PubMed ID: 17910429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of the HIV-1 reverse transcriptase 'AZT-resistant' mutant with substrates and AZT-TP.
    Pokholok DK; Gudima SO; Yesipov DS; Dobrynin VN; Rechinsky VO; Kochetkov SN
    FEBS Lett; 1993 Jul; 325(3):237-41. PubMed ID: 7686510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleoside drug resistance in HIV-1 reverse transcriptase.
    Yadav PN; Yadav JS; Modak MJ
    Nat Struct Biol; 1995 Mar; 2(3):193-5. PubMed ID: 7539709
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of the RNase H activity of HIV reverse transcriptase by azidothymidylate.
    Tan CK; Civil R; Mian AM; So AG; Downey KM
    Biochemistry; 1991 May; 30(20):4831-5. PubMed ID: 1709809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.